TKT and hematologic disorder: Numerous clinical trials have explored CAR-Ts containing the HSV-TK gene for hematological malignancies.A Phase I/II clinical trial investigated the HSV-TK Mut2 gene in anti-CD44v6 CAR T-cells in R/R MM patients (NCT04097301) [185].